Brooks Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 243.15 million compared to INR 180.81 million a year ago. Revenue was INR 244.07 million compared to INR 182.18 million a year ago. Net loss was INR 16.37 million compared to INR 46.82 million a year ago. Basic loss per share from continuing operations was INR 0.64 compared to INR 3.19 a year ago. Diluted loss per share from continuing operations was INR 0.64 compared to INR 3.19 a year ago.
For the six months, sales was INR 400.18 million compared to INR 352.05 million a year ago. Revenue was INR 401.65 million compared to INR 353.76 million a year ago. Net loss was INR 61.08 million compared to INR 115.83 million a year ago. Basic loss per share from continuing operations was INR 2.38 compared to INR 6.99 a year ago. Diluted loss per share from continuing operations was INR 2.38 compared to INR 6.99 a year ago.